01. Penicillin and cephalosporin products are operating smoothly overall.
Amoxicillin, in the third week of 2026, experienced fluctuating market conditions, with a market price of around 166, a month-on-month increase of 0.5%, and a year-on-year decrease of over 20%. Amoxicillin sodium, with a market price of 300-355, remained basically unchanged compared to last week's price, with a year-on-year decrease of over 20%. The market trend in January was stable.
Amoxicillin and clavulanate potassium have seen a relatively weak performance, with a market price of 500 and a month-on-month decrease of 0.5%, while the year-on-year decrease has exceeded 30%.
Ampicillin, with a market price of 175, has seen a month-on-month decrease of 1.3% and a year-on-year decrease of over 20%. The market trend in January was stable.
Ampicillin sodium, with a relatively weak performance, has a market price ranging from 275 to 315, with a month-on-month decrease of 0.6% and a year-on-year decrease of 16.5%.
Penicillin sodium, with a market price of 115/billion, has seen a month-on-month decrease of 0.3% and a year-on-year decrease of over 30%.
Penicillin potassium industrial salt, with a market price of 65/billion, remains basically unchanged from last week's price. The trading market has seen an increase in brands, with ample supply. Bulk transaction prices are negotiable.
Ceftiofur sodium, cefotiofur hydrochloride, and cefquinome sulfate come in different levels of sterility and non-sterility, with a wide price range. Ceftiofur sodium, which is relatively weak in performance, has a price range of 830-955, with a month-on-month decrease of 0.9% and a year-on-year decrease of nearly 20%. Cefotiofur hydrochloride has a market price of 800-910, with a month-on-month decrease of 0.8% and a year-on-year decrease of 15.7%. Cefquinome sulfate has a market price of 3600-4500, which is basically the same as the price of last week, with a year-on-year decrease of 14.1%. The average prices for the same period in the past five years from 2025 to 2021 are 4950, 5600, 6350, 6900, and 6500, respectively.
The original article is copyrighted by Asia-Pacific Easy and Data Analysis Research Institute. The market data analysis pertains to the comprehensive prices of bulk products and should not be used as a basis for investment.
02. Chloramphenicol and tetracycline products show an overall stable trend.
Fluoroquinolone, with a market price of around 165, has experienced fluctuating adjustments in the market, with a month-on-month decrease of 1.3% and a year-on-year decrease of 13.5%. It remains highly popular with active trading, and there is ample room for price negotiation in bulk transactions. It is a product worthy of attention from the Asia-Pacific Easy and Data Analysis Research Institute.
Thiamphenicol has a stable market situation, with a market price of 172. The month-on-month decrease is 0.6%, and the year-on-year decrease is 8.9%. The average prices for the same period in the past three years from 2025 to 2023 are 202, 236, and 363 respectively. The market situation in January remains stable.
Doxycycline hydrochloride has been in high demand, with the market rebounding after New Year's Day. However, it has recently fallen back to around 315, with a month-on-month decrease of 0.8% and a year-on-year decrease of 6.2%. The upward pressure is significant.
Overview of doxycycline hydrochloride market data in 2025: In the first half of the year, the average price in January was 380 yuan, reaching a bottom of 335 yuan in early April. The price per kilogram rebounded by 30 yuan in early May. In the third quarter, it fluctuated around 350 yuan. After mid-November in the fourth quarter, the decline accelerated, and the year-end closing price was slightly higher than the 300 yuan mark. There are 12 veterinary drug active pharmaceutical ingredient (API) approval numbers and 3,052 preparation approval numbers. For aureomycin hydrochloride, the market price is 155 yuan, down from the previous week's market, with a year-on-year decrease of 8.3%.
Oxytetracycline and oxytetracycline hydrochloride. The market price of oxytetracycline is 80, with a month-on-month decrease of 2.6% and a year-on-year increase of 3.1%. The market price of oxytetracycline hydrochloride is 100, with a month-on-month decrease of 0.4% and a year-on-year increase of over 10%. The average prices for the same period in the past five years from 2025 to 2021 are 99, 94, 99, 102, and 108, respectively.
Overview of oxytetracycline and oxytetracycline hydrochloride market data in 2025: Oxytetracycline opened low and went high in the first half of the year. The transaction prices from January to May showed a steady increase, with a significant rise in June, reaching the 80-line mark. The third quarter saw a stable trend, with an average price of 79, and the fourth quarter gradually fell back to around 75. Oxytetracycline hydrochloride started at 95 in the first half of the year, gradually decreased by nearly 10% from January to April, reaching a low of 85. In late April, it rose in a spiral manner, and by the end of October and early November, the trading market exceeded the 100-line mark, before falling below 100 by the end of the year.
Chlortetracycline hydrochloride, with a market price of 153, has decreased by 8.7% compared to the previous week's market situation.
Overview of Chlortetracycline Hydrochloride Market Data in 2025: The price range in the first quarter of the first half of the year was 175-160. There was a slight rebound at the end of April, followed by a gradual decline in June. The average prices in the third and fourth quarters were 169 and 159 respectively.
03. Amino glycosides: The overall performance of amino glycosides products is relatively weak.
Neomycin sulfate, with a market price of around 155/billion, has seen a month-on-month decrease of 0.4% and a year-on-year decrease of 3.7%. The current market is in the stage of destocking, with increasing downward pressure. The average prices from 2025 to January 2023 were 160, 133, and 150 respectively.
Streptomycin sulfate has a stable market situation, with a price range of 265-305/billion.
Amprolium sulfate, with a market price of 199, remains unchanged compared to last week's price, with a year-on-year decrease of 7.1%. The average prices from 2025 to January 2023 were 212, 219, and 200 respectively, indicating a strong market trend in January.
Kanamycin monosulfate, with a market transaction price of 295/billion, saw a month-on-month decrease of 0.3%, while the year-on-year price remained basically unchanged, maintaining a stable trend in January.
Amikacin sulfate, with a relatively weak performance, has a market price of 745. It has decreased by 0.8% month-on-month and has fallen by more than 10% year-on-year. The market trend in January was stable.
Spectinomycin dihydrochloride (sulfate) has seen an easing of supply, with a market price of 555. The month-on-month decrease is 2.6%, while the year-on-year increase exceeds 20%. Transaction prices vary significantly across regions and brands, with a weak market trend observed in January.
Gentamicin sulfate, with a market price of 1050-1150/billion, remains basically unchanged compared to last week's market, but has decreased by nearly 20% year on year.
04. Macrolides and other macrolide-type antibiotics have been performing relatively weakly overall.
Tylosin Tartrate, with a market price of around 280, has decreased compared to last week's market situation, with a year-on-year increase of over 20%. The average prices for the same period in 2025, 2024, and 2023 were 218, 245, and 292 respectively.
Tilmicosin and tilmicosin phosphate. Tilmicosin, with a market price of 365, has a month-on-month decrease of 0.6%, while its year-on-year increase exceeds 20%; tilmicosin phosphate, with a market price of around 319, has a month-on-month decrease of 1.2%, while its year-on-year increase is 25.9%. There is a large bargaining space for bulk trading prices.
Tartaric acid kitasamycin, market price 356.
Tylvalosin tartrate, which is relatively weak in operation, has a market price of 390. It has decreased by 2.3% month-on-month and increased by 6.1% year-on-year. The market trend in January was downward, and Asia-Pacific Easy and Data Analysis Research Institute focused on this product.
Tylosin, market price 8000.
Erythromycin thiocyanate, with a market transaction price of 490, has seen a month-on-month decrease of 2.1% and a year-on-year decrease of 2.2%.
Sulfate colistin, operating smoothly, with a market price of 113.
Tylosin fumarate, after a period of consolidation, has a market price of 249, with a month-on-month decrease of 1.7% and a year-on-year increase of over 10%.
Lincomycin hydrochloride has a stable market situation, with a market price of 329 yuan/billion, a month-on-month decrease of 0.5%, and a decrease of nearly 100 yuan compared to the price of the same period last year.
Original article from Asia-Pacific Easy Data Analysis Research Institute. Reproduction without permission is prohibited. All rights reserved. For reproduction and quotation, please contact the author and indicate the original source.
05. Quinolones Quinolones experienced low-level fluctuations.
Enrofloxacin and enrofloxacin hydrochloride. The current market price is 168, with a year-on-year decrease of over 10%.
Ciprofloxacin lactate (hydrochloride), priced at 160, has a stable market trend, with a year-on-year decrease of 10.6%. The average prices from 2025 to December 2023 were 175, 191, and 215 respectively.
Sarafloxacin hydrochloride has a stable market situation, with a current market price of 400.
Mapofloxacin, with a market price of 2380, has seen a month-on-month decrease of 0.9% and a year-on-year decrease of 15.1%.
Overview of Quinolones Market Data in 2025: The market for quinolones exhibited an overall trend of initial stability followed by a decline, with a deep correction in the second half of the year. Enrofloxacin saw a moderate increase from 185 yuan at the beginning of the year, reaching an annual peak of 189 yuan in June. However, the market reversed direction in the second half, and prices entered a downward trend, with the decline accelerating significantly in the fourth quarter. Prices fell from 179 yuan to an annual low of 165 yuan, forming a deep correction. The price of L-(-)-(-)-(+)-(-)-2,3-dideoxy-D-ribo-3-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-2-amino-2,3-dideoxy-D-ribo-2-en-3,5-oligo-L-(-)-(-)-(+)-(-)-.
06. Sulfa drugs Sulfa products have shown an overall stable trend.
Sulfamethoxazole (sodium) has a trading market price range of 185-230, with average prices of 208, 204, and 282 for the years 2025, 2023, and January 2023, respectively.
The current market price of sulfamethoxazole (sodium) is around 245.
Sulfamethoxazole (sodium) has a stable market situation, with a price range of 105-145. It has decreased by 0.5% month-on-month and increased by 3.1% year-on-year.
Sulfadiazine (sodium) is currently priced at 150 in the market, with the average prices for the same period in 2025-2023 being 160, 175, and 210 respectively.
Sulfamethazine (sodium) has maintained a stable market trend, with a market price of 99. Compared to last week, the price remains basically unchanged, and the year-on-year increase is 24.4%. The average prices for the same period in 2025, 2022, and 2023 were 80, 78, and 110, respectively.
Sulfamethoxazole sodium, with a current market price of 195, remains basically unchanged compared to last week's price, but has increased by more than 20% year-on-year. The average prices from 2025 to January 2023 were 165, 178, and 307 respectively.
Sulfamethoxazole and Chlorpheniramine Sodium have a relatively strong performance, with a market price of 215. The average prices from 2025 to January 2023 were 218, 230, and 313 respectively.
Sulfamethazine sodium, with relatively strong performance, has a market price of 179, which is basically unchanged from the price of last week, with a year-on-year increase of 2.3%. The average prices from 2025 to January 2023 were 174, 147, and 169 respectively.
Dimethoprim, with a stable trend, has a market price of 380.
Trimethoprim and lactobionyl trimethoprim are operating at a relatively low level. The market price of trimethoprim is 238, while that of lactobionyl trimethoprim is 188.
07. Antiparasitic drugs: The market for some antiparasitic drugs has seen an increase.
Abendazole, with relatively strong performance, has a market price of 135, with a month-on-month increase of 0.5% and a year-on-year decrease of over 10%.
Fenbendazole, with relatively strong performance, has a market price of 226, showing a month-on-month increase of 1.3% and a year-on-year decrease of 12.7%.
Avermectin, operating at a slightly weak level, is traded at a price of 530-610.
Ivermectin, with a relatively weak performance, has a market price of 765. The average prices for the same period in the past five years from 2025 to 2021 are 765, 925, 1130, 1520, and 1280 respectively.
Diclazuril, with a market price of 980, has decreased compared to last week's market, with a year-on-year decrease of 3.1%.
Toltrazuril, market price 830.
Levamisole hydrochloride is performing relatively strongly, with a market price of 355, a month-on-month increase of 1.1%, and a year-on-year increase of over 10%.
Amprolium hydrochloride, with a relatively strong performance, has a market price of 333.
Metronidazole, with a market price of 88, has average prices of 78, 80, and 88 for the same period from 2025 to 2023.
Demenidazole, with a market price of 99, remains basically unchanged compared to last week's price, with a year-on-year increase of 6.7%. The average prices for the same period from 2025 to 2023 were 88, 114, and 119 respectively.
Praziquantel, with a market price of 300, has seen a month-on-month decrease of 0.3%, and a year-on-year decrease of over 10%.
Cyromazine, with a relatively weak operational effect, has a market price of 112.
To learn more, please join the Asia-Pacific Easy Data Analysis Research Institute as a member to stay updated on market changes in real-time.
08. Products for fever relief and analgesia, asthma relief, and immunity enhancement showed a stable overall trend.
Flunixin meglumine has a stable market situation, with a market price of 372, a month-on-month increase of 0.3%, and a year-on-year decrease of over 10%.
Analgin, a strong performer, has a market price of around 85, with a month-on-month increase of 1.4% and a year-on-year decrease of 3.1%.
Acetaminophen, with relatively strong performance, has a market price of 24, slightly higher than the market price of last week, with a year-on-year decrease of 4.9%.
Aminopyrine, with a market price of 100, has remained stable compared to last week's market conditions, with a year-on-year decrease of 2.9%.
Aminophylline, with a market price of 116, and aspirin, which is relatively weak in operation, with a market price of 19,800/ton.
Taurine, with its market price on the rise, has a transaction price of 16,400/ton, marking a month-on-month increase of 1.2% and a year-on-year increase of 11.3%. The tonnage prices for the same period from 2025 to 2023 were 14,600, 17,200, and 24,300, respectively.
Carbasalate calcium is currently undergoing price adjustment due to market fluctuations. The market transaction price is 29. The average prices for the past three years, from 2025 to 2023, are 35, 35, and 38 respectively.
09. Veterinary drug excipients and other types of acepromazine, with a market price of 48, are experiencing volatile market conditions.
Sodium camphor sulfonate, market price 52, with market conditions fluctuating and consolidating.
Chlorpheniramine, with a market price of 150, saw a month-on-month increase of 1.3% and a year-on-year decrease of 14.3%. The market trend in January was relatively strong.
Sodium salicylate, with a rising market, has a trading price of 25,800/ton.
Citric acid, with a rising market trend, has a market price of 4450/ton.
Sodium citrate has been steadily increasing, with a market price of 4600/ton.
Sodium carbonate, with a stable but slightly declining market, is priced at 2200/ton.
Sodium bicarbonate, with a stable yet slightly declining market trend, is priced at 2500 yuan/ton.
Glucose, with a trading price of 3960-6200/ton, has increased compared to last week's market.
Jiayi powder, trading price at 2710-3200/ton, up from last week's market.
Soluble starch, operating at a relatively strong level, has a market price of 12,900/ton.
Beta-cyclodextrin, with strong performance, has a market price of 18,900/ton.
10. The overall trend of plant-based traditional Chinese medicinal materials remains stable.
Shuanghuanglian extract, 46-80.
Astragalus polysaccharide extract, 49-110.
Scutellaria baicalensis extract, 125-150.
Licorice extract, 60-95.
Honeysuckle extract, 75-135.
Honeysuckle, 70-110.
Huanglian, 240-290.
Astragalus, 7-12.
Scutellaria, 22-29.
Yanhusuo, 55-65.
Chenpi, 10-13.
Hawthorn, 8-12.
Licorice, 19-30.
Dried ginger, 16-25.
Safflower, 62-80.
Banlangen, 18-29.
11. Vitamin products: The overall price of vitamin products is low.
VA, operating at a low level, with a mixing ratio of 59-65, and a water solubility of 85.
VB1, market stable, nitric acid 238, hydrochloric acid 290.
VB2, 98% purity at a price of 270, 80% purity at a price of 70.
VB6, with a stable market, has a market price of 112.
VB12, 1%, market price around 90, with a stable market trend.
VC, the market quotation is around 20 for feed grade and 28 for pharmaceutical grade.
VD3, market price for mixing is 145, water solubility is 165, showing a downward trend.
VE, oscillating downward, mixing ratio 60, water solubility 99.
VK3, market price 70, downward trend.
Calcium pantothenate, stable operation, market price 42.
Nicotinamide, with a market price of 40, has a stable market situation.
Biotin 2%, market price 30.
Folic acid, market price 385.
10个月宝宝每天需要喝多少奶粉？
